Association of Cardiovascular Disease, Respiratory Diseases, and Diabetes Treatment With COVID-19 Mortality in Hospitalized Patients
International Journal of Drug Research in Clinics · 2023
DOI: 10.34172/ijdrc.2023.e21 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Research in Clinics, 2023. Verfasst von Zeinab Nikniaz und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The prevalence of the coronavirus disease 2019 (COVID-19) in patients with preexisting non-communicable disease was high, and there was a question regarding the effect of the usage of medications on COVID-19 outcomes in these patients. Therefore, this study investigated the outcome of patients with different cardiovascular diseases (CVDs), respiratory diseases, and diabetes drug use.
Methods
In this analytical longitudinal study, information was collected on clinical laboratory data, COVID-19 severity, comorbidities, and drug use. The follow-up time was from enrollment to discharge or death.
Results
A total of 1046 hospitalized patients with COVID-19 participated in this analytical longitudinal study. The most commonly used drugs were CVD drugs (39.4%) and diabetes drugs (19.7%). The frequency of drug use was statistically similar between survivors and non-survivors except for diabetic drug use which was significantly higher in non-survivors (P=0.04). Patients who used the diabetic drugs were more likely to die (odds ratio [OR]: 1.41, 95% CI: 1.008-1.97). Moreover, the association was not significant after adjusting to confounding factors, and there was no significant association between other drug use and death in patients with COVID-19.
Conclusion
The result of the present study showed that antihypertensive treatments, antidiabetic, and respiratory disease drugs were not associated with higher deaths in hospitalized patients with COVID-19.
Zitieren
APA
Nikniaz, Z., Dinevari, M. F., & Mokhtari, L. (2023). Association of Cardiovascular Disease, Respiratory Diseases, and Diabetes Treatment With COVID-19 Mortality in Hospitalized Patients. International Journal of Drug Research in Clinics. https://doi.org/10.34172/ijdrc.2023.e21
Vancouver
Nikniaz Z, Dinevari MF, Mokhtari L. Association of Cardiovascular Disease, Respiratory Diseases, and Diabetes Treatment With COVID-19 Mortality in Hospitalized Patients. International Journal of Drug Research in Clinics. 2023. doi:10.34172/ijdrc.2023.e21
BibTeX
@article{Nikniaz2023,
author = {Nikniaz, Zeinab and Dinevari, Masood Faghih and Mokhtari, Leila},
title = {Association of Cardiovascular Disease, Respiratory Diseases, and Diabetes Treatment With COVID-19 Mortality in Hospitalized Patients},
journal = {International Journal of Drug Research in Clinics},
year = {2023},
doi = {10.34172/ijdrc.2023.e21}
}
EUVIMED